Legal & General Group PLC Gilead Sciences, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 12,414,268 shares of GILD stock, worth $1.04 Billion. This represents 0.19% of its overall portfolio holdings.

Number of Shares

12,414,268

Previous 12,321,200 0.76%

Holding current value

$1.04 Billion

Previous $903 Million 5.63%

% of portfolio

0.19%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $5.88 Million - $6.78 Million	93,068 Added 0.76%	12,414,268 $852 Million
Q1 2024 Jul 01, 2024	BUY	$71.58 - $87.29 $4.94 Million - $6.02 Million	68,946 Added 0.56%	12,321,200 $903 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $15 Million - $18.3 Million	-209,869 Reduced 1.68%	12,252,254 $897 Million
Q4 2023 Feb 15, 2024	BUY	$73.27 - $83.09 $149 Million - $169 Million	2,030,334 Added 19.46%	12,462,123 $1.01 Billion
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $28.6 Million - $31.2 Million	-387,292 Reduced 3.58%	10,431,789 $782 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $19 Million - $21.7 Million	249,984 Added 2.37%	10,819,081 $834 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $9.1 Million - $10.4 Million	-117,726 Reduced 1.1%	10,569,097 $877 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $24.5 Million - $35.2 Million	-393,685 Reduced 3.55%	10,686,823 $917 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $15.8 Million - $18.1 Million	-265,779 Reduced 2.34%	11,080,508 $684 Million
Q2 2022 Aug 22, 2022	SELL	$57.72 - $65.01 $15.1 Million - $17.1 Million	-262,474 Reduced 2.26%	11,346,287 $701 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $48.2 Million - $60.4 Million	832,109 Added 7.72%	11,608,761 $690 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $1.62 Million - $1.84 Million	-24,955 Reduced 0.23%	10,776,652 $782 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $34.1 Million - $36.8 Million	503,977 Added 4.89%	10,801,607 $754 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $62.5 Million - $68.3 Million	984,246 Added 10.57%	10,297,630 $709 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $3.07 Million - $3.5 Million	-51,164 Reduced 0.55%	9,313,384 $602 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $14.7 Million - $16.8 Million	260,037 Added 2.86%	9,364,548 $546 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $2.76 Million - $3.47 Million	-44,489 Reduced 0.49%	9,104,511 $575 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $47.2 Million - $54.8 Million	652,642 Added 7.68%	9,149,000 $704 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $13.5 Million - $17.3 Million	216,005 Added 2.61%	8,496,358 $635 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $18.8 Million - $20.7 Million	305,577 Added 3.83%	8,280,353 $538 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $3.77 Million - $4.16 Million	60,307 Added 0.76%	7,974,776 $505 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $5.51 Million - $6.18 Million	89,045 Added 1.14%	7,914,469 $535 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $79.6 Million - $89.2 Million	1,273,193 Added 19.43%	7,825,424 $509 Million
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $24.8 Million - $32.3 Million	408,910 Added 6.66%	6,552,231 $410 Million
Q3 2018 Nov 20, 2018	BUY	$71.28 - $78.92 $729,907 - $808,140	10,240 Added 0.17%	6,143,321 $474 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $29.3 Million - $34.2 Million	-451,480 Reduced 6.86%	6,133,081 $434 Million
Q1 2018 May 17, 2018	SELL	$72.84 - $88.8 $28.2 Million - $34.4 Million	-387,134 Reduced 5.55%	6,584,561 $496 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $496 Million - $582 Million	6,971,695	6,971,695 $499 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Gilead Sciences, Inc. Transaction History